KRAS ‐ G12C : The neglected biomarker to detect patients with MUTYH ‐associated polyposis
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70281 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Ana Beatriz Deleame Medeiros und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Functional Genomics, A. C. Camargo Cancer Center, São Paulo, Brazil. Hauptthemen laut MEDLINE: DNA Glycosylases, Proto-Oncogene Proteins p21(ras), Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Public Ministry of Labor Campinas, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
MUTYH ‐associated polyposis (MAP) is an underdiagnosed recessive syndrome that predisposes individuals to colorectal cancer (CRC) and exhibits phenotypic variability. Biallelic MUTYH inactivation leads to a somatic mutational signature with frequent KRAS ‐G12C mutations; however, despite being proposed as a marker for MAP, germline MUTYH testing in these patients remains limited. We assessed the utility of screening germline pathogenic variants (GPVs) in MUTYH among CRC cases with KRAS ‐G12C. A cohort of 220 KRAS ‐G12C CRC patients from two Brazilian oncology centers underwent targeted amplicon sequencing for the most prevalent MUTYH GPVs in Brazil. Comprehensive MUTYH sequencing was subsequently performed for monoallelic carriers. Overall, 25 (11.4%) patients carried at least one MUTYH GPV; among these, 15 (6.8%) were biallelic and classified as MAP and 10 (4.5%) were monoallelic. The MAP detection rate was 10.9% in patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Functional Genomics, A. C. Camargo Cancer Center, São Paulo, Brazil.
- Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil.
- Oncogenetics Department, A. C. Camargo Cancer Center, São Paulo, Brazil.
- Colorectal Tumors Reference Center, A. C. Camargo Cancer Center, São Paulo, Brazil.
- Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
- Oncogenetics Department, Barretos Cancer Hospital, Barretos, Brazil.
ORCID-Profile: Rui Manuel Reis, Dirce Maria Carraro, Giovana Tardin Torrezan
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Public Ministry of Labor Campinas
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Hospital de Câncer de Barretos
- Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
Zitieren
APA
Medeiros, A. B. D., Dos Santos, G. O., Casali-da-Rocha, J. C., Junior, S. A., Souza E Silva, V., Berardinelli, G. N., Antoniazzi, A. P., Reis, R. M., Carraro, D. M., & Torrezan, G. T. (2026). KRAS ‐ G12C : The neglected biomarker to detect patients with MUTYH ‐associated polyposis. International Journal of Cancer. https://doi.org/10.1002/ijc.70281
Vancouver
Medeiros ABD, Dos Santos GO, Casali-da-Rocha JC, Junior SA, Souza E Silva V, Berardinelli GN, et al. KRAS ‐ G12C : The neglected biomarker to detect patients with MUTYH ‐associated polyposis. International Journal of Cancer. 2026. doi:10.1002/ijc.70281
BibTeX
@article{Medeiros2026,
author = {Medeiros, Ana Beatriz Deleame and Dos Santos, Gabriel Oliveira and Casali-da-Rocha, José Claudio and Junior, Samuel Aguiar and Souza E Silva, Virgilio and Berardinelli, Gustavo Nóriz and Antoniazzi, Augusto Perazzolo and Reis, Rui Manuel and Carraro, Dirce Maria and Torrezan, Giovana Tardin},
title = {KRAS ‐ G12C : The neglected biomarker to detect patients with MUTYH ‐associated polyposis},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70281}
}
EUVIMED